Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy TA1126 28 January 2026 28 January 2026 Concizumab for treating ...
Creates a complete new DAB environment from scratch. The current user will need an Azure subscription as well as authority to create. All resource names are automatically validated and sanitized ...
Proyecto académico para la materia SOFG1006 — "Desarrollo de Aplicaciones Web y Móviles" (ESPOL). Sistema modular para gestionar eventos: clientes, boletos, facturación y notificaciones. Estado: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results